Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG.
Yan GuYanfang LiuLi FuLili ZhaiJie ZhuYanmei HanYingming JiangYi ZhangPeng ZhangZhengping JiangXiang ZhangXue-Tao CaoPublished in: Nature medicine (2019)
Primary tumors may create the premetastatic niche in secondary organs for subsequent metastasis. Humoral immunity contributes to the progression of certain cancers, but the roles of B cells and their derived antibodies in premetastatic niche formation are poorly defined. Using a mouse model of spontaneous lymph node metastasis of breast cancer, we show that primary tumors induced B cell accumulation in draining lymph nodes. These B cells selectively promoted lymph node metastasis by producing pathogenic IgG that targeted glycosylated membrane protein HSPA4, and activated the HSPA4-binding protein ITGB5 and the downstream Src/NF-κB pathway in tumor cells for CXCR4/SDF1α-axis-mediated metastasis. High serum anti-HSPA4 IgG was correlated with high tumor HSPA4 expression and poor prognosis of breast cancer subjects. Our findings identify a key role for tumor-educated B cells and their derived antibodies in lymph node premetastatic niche formation, providing potential targets for cancer intervention.
Keyphrases
- lymph node metastasis
- papillary thyroid
- poor prognosis
- lymph node
- heat shock protein
- squamous cell carcinoma
- long non coding rna
- binding protein
- mouse model
- signaling pathway
- immune response
- randomized controlled trial
- neoadjuvant chemotherapy
- cancer therapy
- childhood cancer
- high glucose
- tyrosine kinase
- early stage
- squamous cell
- pi k akt
- locally advanced